To view this site you must be a
veterinarian surgeon or nurse.
Are you a Veterinary Surgeon or Veterinary Nurse?



  1. Comparison of pain on injection during induction of anaesthesia with alfaxalone and two formulations of propofol in dogs, Michou et al, Vet Anaesth Anal
  2. A comparison of anaesthetic recoveries in cats following induction with either alfaxalone or ketamine and diazepam, Gieseg et al, 2013, NZVJ
  3. Induction of anaesthesia for canine caesarean section with alfaxalone, Reproductive Biology, 2013
  4. Vettorato E. Prolonged intravenous infusion of alfaxalone in a cat. Vet Anaesth Analg 09/13;40:551–2.
  5. Seymour C, Duke-Novakovski T, British Small Animal Veterinary Association. BSAVA manual of canine and feline anaesthesia and analgesia. Gloucester, England: British Small Animal Veterinary Association; 2007.
  6. Seebacher, F. and C.E. Franklin, Redistribution of blood within the body is important for thermoregulation in an ectothermic vertebrate (Crocodylus porosus).J Comp Physiol B, 2007. 177(8): p. 841-8.
  7. O’Hagan, B.J. and S.R. Raidal, Surgical removal of retrobulbar hemangioma in a goldfish (Carassius auratus).Vet Clin North Am Exot Anim Pract, 2006. 9(3): p. 729-33. http://www.vetexotic.theclinic...
  8. NHMRC, NHMRC Guideline to promote well being of animals for scientific purposes.2008.
  9. McMillan, W. and E.A. Leece, Immersion and branchial/transcutaneous irrigation anaesthesia with alfaxalone in a Mexican axolotl.Vet Anaesth Analg, 2011. 38: p. 619-623
  10. Leece, E.A., N.M. Girard, and K. Maddern, Alfaxalone in cyclodextrin for induction and maintenance of anaesthesia in ponies undergoing field castration.Veterinary Anaesthesia and Analgesia, 2009. 36(5): p. 480-484
  11. Keates, H., Induction of anaesthesia in pigs using a new alphaxalone formulation.Vet Rec, 2003. 153(20): p. 627-8
  12. Grint, N.J., et al. A comparison of two doses of alfaxalone used for intravenous induction of anaesthesia in rabbits. in Association of Veterinary Anaesthetists Autumn Meeting.2007. Leipzig, Germany
  13. Goodwin, W.A., et al., The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse.Veterinary Anaesthesia and Analgesia, 2011. 38(5): p. 431-438
  14. Gil, A.G., et al., Heart and respiratory rates and adrenal response to propofol or alfaxalone in rabbits Veterinary Record, 2012. 170(17): p. 444.
  15. Bertelsen, M.F. and C.D. Sauer, Alfaxalone anaesthesia in the green iguana (Iguana iguana). Veterinary Anaesthesia and Analgesia, 2011. 38(5): p. 461-466.
  16. Leyonhjelm, D., Anaesthesia Market Research.2011, Jurox Pty Limited, Baron Strategic Services. Jurox in House
  17. Brodbelt, D.C.,et al., The risk of death: the confidential enquiry into perioperative small animal fatalities.Vet Anaesth Analg, 2008. 35(5): p. 365-73
  18. Glasgow University short form composite measure pain score (CMPS-SF). 2012
  19. Sear, J.W., C. Prys-Roberts, and K.C. Phillips, Age influences the minimum infusion rate (ED50) for continuous infusions of Althesin and methohexitone.Eur J Anaesthesiol, 1984. 1(4): p. 319-25
  20. Patten, B., et al., RD9604.03/06 The Safety of Jurox Alfaxan®-CD Anaesthetic Injection in dogs. 2000, Jurox in house
  21. Patten, B., et al., RD9604.03/01 The Safety of Alfaxalone-Cyclodextrin Complex in cats.1998, Jurox in House
  22. Whittem, T. and K. Pasloske, JX9604.03-E013 The in-vitro metabolism and clearance of the neurosteroid, alfaxalone, by cat and dog hepatocytes at concentrations of 1, 5, 10 and 100 mg/L. 2005, Jurox In House Report
  23. Whittem, T., et al., The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan®at clinical and supraclinical doses. J Vet Pharmacol Ther, 2008. 31(6): p. 571-9
  24. Dugdale, A.H.A., Veterinary Anaesthesia: Principles to Practice.2010: Wiley-Blackwell.
  25. Weingart, S.D. and R.M. Levitan, Preoxygenation and Prevention of Desaturation During Emergency Airway Management.Annals of emergency medicine, 2012. 59(3): p. 165-175.e1 http://www.emergencymedicine.u...
  26. Zaki, S., K. Ticehurst, and Y. Miyaki, Clinical evaluation of Alfaxan®-CD(R) as an intravenous anaesthetic in young cats.Aust Vet J, 2009. 87(3): p. 82-7
  27. Psatha, E., et al., Clinical efficacy and cardiorespiratory effects of alfaxalone, or diazepam/fentanyl for induction of anaesthesia in dogs that are a poor anaesthetic risk.Vet Anaesth Analg, 2011. 38: p. 24-36.
  28. Murison, P.J. and Martinez Taboada, F. Effect of propofol and alfaxalone on pain after ovariohysterectomy in cats Vet Rec., 2010. 166(11): p. 334-335
  29. Mathis, A., et al., Comparison of quality of recovery from anaesthesia in cats induced with propofol or alfaxalone.Veterinary Anaesthesia and Analgesia, 2012. 39(3): p. 282-290
  30. Martinez Taboada, F. and P.J. Murison, Induction of anaesthesia with alfaxalone or propofol before isoflurane maintenance in cats.Veterinary Record, 2010. 167(3): p. 85-89
  31. Maddern, K., et al., Alfaxalone induction dose following administration of medetomidine and butorphanol in the dog. Veterinary Anaesthesia and Analgesia, 2010. 37(1): p. 7-13.
  32. Jimenez, C.P., et al., Evaluation of the quality of the recovery after administration of propofol or alfaxalone for induction of anaesthesia in dogs anaesthetized for magnetic resonance imaging. Veterinary Anaesthesia and Analgesia, 2012. 39(2): p. 151-159
  33. Jansen, K.S. and J.J. Uilenreel, A comparison between alfaxalone and propofol continuous rate infusions in a total intravenous anaesthesia protocol for canine surgical patients.2009, Faculty of Veterinary Medicine - University of Utrecht
  34. Herbert, G.L.,et al., Alfaxalone for total intravenous anaesthesia in dogs undergoing ovariohysterectomy: a comparison of premedication with acepromazine or dexmedetomidine. Veterinary Anaesthesia and Analgesia, 2012.
  35. Amengual, M.,et al., An evaluation of anaesthetic induction in healthy dogs using rapid intravenous injection of propofol or alfaxalone.Veterinary Anaesthesia and Analgesia, 2012
  36. ASA Physical Status Classification System,Amer Soc Anesth. For-Members/Clinical-Information/ASA-Physical-Status-Classification-System
  37. Metcalfe, S., et al. A multi-centre clinical trial evaluating the efficacy and safety of Alfaxan® administered to bitches for induction of anaesthesia prior to caesarean sectionin 33 rd World Small Animal Congress.2008. Dublin, Ireland: WSAVA/FECAVA
  38. O’Hagan, B., et al., Clinical evaluation of alfaxalone as an anaesthetic induction agent in dogs less than 12 weeks of age.Australian Veterinary Journal, 2012. 90(9): p. 346-50
  39. O’Hagan, B., et al., Clinical evaluation of alfaxalone as an anaesthetic induction agent in cats less than 12 weeks of age.Australian Veterinary Journal, 2012. 90(10): p. 395-401
  40. Jurox, NADA 141-342 Alfaxan® Intravenous injectable anesthetic for use in cats and dogs. Product Insert.2012, USFDA
  41. Child, K.J., et al. Metabolism and excretion of CT1341 in the Steroid Anaesthesia.1972. Royal College of Physicians, London
  42. Heit, M.C., et al. Cardiovascular and respiratory safety of Alfaxan®CD RTU in cats premedicated with acepromazine, medetomidine, midazolam or ACVIM.2004
  43. Pasloske, K., et al., Plasma pharmacokinetics of alfaxalone in both premedicated and unpremedicated Greyhound dogs after single, intravenous administration of Alfaxan® at a clinical dose.Journal of Veterinary Pharmacology and Therapeutics, 2009. 32: p. 510-513.
  44. Ambros B, Duke-Novakovski T, Pasloske KS. Comparison of the anesthetic efficacy and cardiopulmonary effects of continuous rate infusions of alfaxalone-2-hydroxypropyl-β-cyclodextrin and propofol in dogs. Am J Vet Res 2008;69:1391–8.
  45. Pasloske, K. and T. Whittem, JX9604.07-H004 A target animal safety study in cats after administration of Alfaxan® -CD RTU as single, repeated injections on days 0, 2, and 5 at dosages of 5, 15 or 25 mg/kg.2004, On File at Jurox
  46. Whittem, T. and K. Pasloske, RD9604.03-H005 Eight day target animal safety study of intravenous Alfaxan® CD RTU in dogs administered every other day.2004, Jurox Pty Limited
  47. Ferre, P.J.,et al., Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan®-CD RTU. Vet Anaesth Analg, 2006. 33(4): p. 229-36.
  48. Schnell, M., et al. Margin of safety of the anesthetic Alfaxan®CD RTU in dogs at 0,1,3 and 5X the intravenous dose of 2 mg/ ACVIM. 2004
  49. Heit, M.C., et al. Safety and efficacy of Alfaxan® CD RTU Administered once to cats subcutaneously at 10 mg/ ACVIM. 2004
  50. Muir, W., et al., Cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alfaxalone in dogs.Vet Anaesth Analg, 2008. 35(6): p. 451-462.
  51. Muir, W.,et al., The cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alfaxalone in cats.Veterinary Anaesthesia and Analgesia, 2009. 36(1): p. 42-54.
  52. Jurox, Jurox Pharmacovigilance report JX9604-SR004.2005. Records on File 
  53. Pasloske, K.,et al. A multicentre clinical trial evaluating the efficacy and safety of Alfaxan® administered to cats for induction and maintenance of British Small Animal Veterinary Association Congress. 2007. Birmingham, UK.
  54. Pasloske, K., et al. A multicentre clinical trial evaluating the efficacy and safety of Alfaxan ® -CD RTU administered to dogs for induction and maintenance of British Small Animal Veterinary Association Congress. 2005. Birmingham, UK
  55. APVMA, Alfaxan ® Anaesthetic Injection Australian Product Insert Leaflet.2010
  56. Mesens, J.L., P. Putteman, and P. Verheyen, Pharmaceutical applications of 2-hydroxypropyl-beta-cylcodextrin., in New trends in cyclodextrins and derivatives., D. Duchene, Editor. 1991: Paris. p. 369-407.
  57. Brewster, M.E., K.S. Estes, and N. Bodor, An intravenous toxicity study of 2-hydroxypropyl- β-cyclodextrin, a useful drug solubilizer, in rats and monkeys.Int J Pharm, 1990. 59: p. 231-243.
  58. Brewster, M.E., K.S. Estes, and N. Bodor, Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins.J Parenter Sci Technol, 1989. 43(6): p. 262-5
  59. Krantz, J.C., et al., XXVI. Pharmacodynamic studies of polyoxyalkylene derivatives of hexitol anhydride partial fatty acid esters.J Pharmacol Exp Ther, 1948. 93(2): p. 188-195.
  60. Child KJ, C.J., Dis B, Dodds MG, Pearce DR, Twissell DJ., The pharmacological properties in animals of CT1341--a new steroid anaesthetic agent.Br J Anaesth, 1971. 43(1): p. 2-13
  61. Phillipps, G.H., Structure-activity relationships in steroidal anaesthetics.J Steroid Biochem, 1975. 6(5): p. 607-613
  62. Belelli, D. and J.J. Lambert, Neurosteroids: endogenous regulators of the GABA(A) receptor.Nat Rev Neurosci, 2005. 6(7): p. 565-575.
  63. Cocker, J.D.,et al., Action of some steroids on the central nervous system of the mouse. Synthetic Methods.J Med Chem, 1964. 8(4): p. 417-425.
  64. Robertson, J.D. and W. Williams, Studies on the clinical and pathological effects of hydroxydione. Anaesthesia, 1961. 16(4): p. 389-401.
  65. P’An, S.Y.,et al., General anesthetic and other pharmacological properties of a soluble steroid, 21-hydroxypregnanedion sodium succinate.J Pharmacol Exp Ther, 1955. 115(4): p. 432-441
  66. Selye, H., Correlations between the chemical structure and the pharmacological actions of the steroids.Endocrinology, 1942. 46: p. 116-121
  67. Selye, H., Anaesthetic effects of steroid hormones.Proceedings of the Society for Experimental Biology, 1941
  68. Roth, F.C. and A. Draguhn, GABA Metabolism and Transport: Effects on Synaptic Efficacy.Neural Plasticity, 2012. 2012.
  69. Jurox and Ricera, An in vitro study evaluating the binding of alfaxalone to various nuclear receptors (Ricerca Study No. AA94464).Records in House, 2010
  70. Brodbelt DC, Blissitt KJ, Hammond RA, Neath PJ, Young LE, Pfeiffer DU, et al. The risk of death: the Confidential Enquiry into Perioperative Small Animal Fatalities. Vet Anaesth Analg. 2008 Sep;35(5):365–73.
  71. Alfaxan Summary Prescribing 
Repeatable. Reliable. Relax.